Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1063785

registered interest
date	18/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what definition will be used by the Government to determine a serious shortage of a medicine that will be used to trigger a Serious Shortage Protocol for a medicine under the Human Medicines (Amendment) Regulations 2019.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	222720
answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The Department has well established processes to manage and mitigate the small number of medicine supply problems that may arise at any one time due to manufacturing or distribution issues and this has always been the case. The Department receives regular reports from the pharmaceutical industry about issues which may potentially interrupt the supply of medicines that may affect United Kingdom patients.</p><p>From January this year, it became a mandatory requirement that pharmaceutical companies must report this information to us in a timely manner.</p><p>A Serious Shortage Protocol (SSP) is an additional tool to manage and mitigate medicine shortages. It would only be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>In the case of a serious shortage, a SSP would only be issued by Ministers if clinicians advised that it was appropriate and after discussion with the manufacturer and/or marketing authorisation holder.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222723 222724 222725 question first answered 21/02/2019 16:16:26 answering member 4067 label Biography information for Steve Brine
tabling member	4127 label Biography information for Julie Elliott

1063789

registered interest
date	18/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Human Medicines (Amendment) Regulations 2019, what process will be followed to consult with relevant health care professionals in the development of advice contained in a Serious Shortage Protocol.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	222724
answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The Department has well established processes to manage and mitigate the small number of medicine supply problems that may arise at any one time due to manufacturing or distribution issues and this has always been the case. The Department receives regular reports from the pharmaceutical industry about issues which may potentially interrupt the supply of medicines that may affect United Kingdom patients.</p><p>From January this year, it became a mandatory requirement that pharmaceutical companies must report this information to us in a timely manner.</p><p>A Serious Shortage Protocol (SSP) is an additional tool to manage and mitigate medicine shortages. It would only be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>In the case of a serious shortage, a SSP would only be issued by Ministers if clinicians advised that it was appropriate and after discussion with the manufacturer and/or marketing authorisation holder.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222720 222723 222725 question first answered 21/02/2019 16:16:26 answering member 4067 label Biography information for Steve Brine
tabling member	4127 label Biography information for Julie Elliott

1063790

registered interest
date	18/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Human Medicines (Amendment) Regulations 2019, what methods the Government plans to use to whether a Serious Shortage Protocol is necessary; what information such a decision would be based on; what level of consultation with medical experts the Government plans to seek on such protocols; and how the Government plans to engage in such consultation.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	222725
answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>The Department has well established processes to manage and mitigate the small number of medicine supply problems that may arise at any one time due to manufacturing or distribution issues and this has always been the case. The Department receives regular reports from the pharmaceutical industry about issues which may potentially interrupt the supply of medicines that may affect United Kingdom patients.</p><p>From January this year, it became a mandatory requirement that pharmaceutical companies must report this information to us in a timely manner.</p><p>A Serious Shortage Protocol (SSP) is an additional tool to manage and mitigate medicine shortages. It would only be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>In the case of a serious shortage, a SSP would only be issued by Ministers if clinicians advised that it was appropriate and after discussion with the manufacturer and/or marketing authorisation holder.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222720 222723 222724 question first answered 21/02/2019 16:16:26 answering member 4067 label Biography information for Steve Brine
tabling member	4127 label Biography information for Julie Elliott